Novartis strikes $1.5B deal for UK biotech Myricx Bio (NVS:NYSE)
· seekingalpha.com
Novartis (NVS) to acquire UK-based biotechnology company Myricx Bio, in a deal worth up to $1.5B,
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...